ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $109 | -99.9% | 24,800 | -81.3% | 0.01% | -35.7% |
| Q3 2022 | $192,000 | -27.3% | 132,346 | +9.0% | 0.01% | -26.3% |
| Q2 2022 | $264,000 | +234.2% | 121,400 | +184.3% | 0.02% | +375.0% |
| Q1 2022 | $79,000 | -6.0% | 42,700 | +221.3% | 0.00% | +33.3% |
| Q4 2021 | $84,000 | +223.1% | 13,291 | -16.9% | 0.00% | +200.0% |
| Q3 2021 | $26,000 | -76.1% | 15,990 | -6.5% | 0.00% | -80.0% |
| Q2 2021 | $109,000 | +75.8% | 17,100 | +235.3% | 0.01% | +66.7% |
| Q1 2021 | $62,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |